AbbVie has announced that the U.S. Food and Drug Administration (FDA) has approved EMBLAVEO (aztreonam and avibactam), as a ...

The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...

AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...

A new study finds that sharks and rays harbor several harmful bacteria, some resistant to antibiotics, raising concerns over their impact on public health.

Ultimately, understanding the microbiota dynamics along gastric carcinogenesis may impact gastric carcinoma prevention and treatment strategies of patients with precancerous disease.

Most of the management guidelines for the treatment of bite infections are based on expert opinion. The goals of therapy are to prevent or treat infection, as well as minimize soft tissue damage.

In addition, prednisolone alone at a dose of 1–1.5 mg/kg/day is still recommended as first line therapy in patients who are not eligible for treatment with RTX or other immunosuppressive adjuvants.

Moreover, owing to the diversity of probiotics, limitations of the technology for extracting single probiotics, and complexity of the mechanism of compound probiotics, applying probiotics to the ...

Expert Rev Anti Infect Ther. 2011;9(2):215-226. As with most mammalian bites, amoxicillin/clavulanic acid (augmentin) is a reasonable empiric antibiotic in an ...

3 The University of Manchester, Manchester Academic Health Science Centre, University Hospital South Manchester NHS Foundation Trust, Manchester, UK 4 University Hospital of South Manchester, ...